3 inside sales jobs found in Boston

argenx Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. Reporting to the Senior Director of US Commercial Finance, the Associate Director US Commercial FP&A will be a key member of the US FP&A team supporting the growing US commercial business. S/he will act as a strategic partner to the...

Ironwood Pharmaceuticals Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. One of the focus areas is on discovering, developing, and commercializing innovative treatments for patients with severe, rare conditions for which there is a significant unmet medical need. These conditions are challenging to diagnose, often devastating, and have limited, if any, treatment options. The lead product candidate, apraglutide, is a next-generation, best-in-class, synthetic peptide analog of glucagon-like peptide-2, or GLP-2, and is in Phase 3 for the treatment of patients with short bowel syndrome, or SBS, a malabsorption disorder caused by the loss of functional small intestine. It is an exciting time to join as Phase 3 is underway and the company is preparing for an initial launch in the coming years for which it is building out a commercial presence....

Revvity Overview Revvity Signals develops market-leading scientific software that helps customers invent better medicines and materials, faster. Our Signals Notebook is the industry-leading, cloud-native scientific notebook used daily by researchers to record the experiments that drive discovery. Through Signals One, we help pharma and biotech companies process data more efficiently, manage complex candidate portfolios, and identify the most promising drug leads. These same capabilities extend into adjacent domains including manufacturing, chemical research, diagnostics, and clinical development. Revvity Signals is now building a next-generation AI-driven discovery platform. This system will enable scientists to generate new molecular or material ideas, predict key chemical and biological properties, automatically evaluate candidates against multi-parameter objectives, and optimize which ones should move to synthesis and testing. We're seeking an entrepreneurial,...